These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3094062)

  • 1. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Fage D; Scatton B
    Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract]   [Full Text] [Related]  

  • 5. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional tolerance to haloperidol-induced catalepsy: striatal dopamine receptor supersensitivity is a possible explanation.
    Hoffman DC; Beninger RJ
    Psychopharmacology (Berl); 1988; 95(1):142-5. PubMed ID: 3133695
    [No Abstract]   [Full Text] [Related]  

  • 7. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats.
    Castelló ME; Bolioli B; Dajas F
    Pharmacol Biochem Behav; 1992 Mar; 41(3):547-50. PubMed ID: 1584833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
    Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
    Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
    Kaneko M; Sato K; Horikoshi R; Yaginuma M; Yaginuma N; Shiragata M; Kumashiro H
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):53-7. PubMed ID: 1378633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB; Rozitis A
    Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Oblin A; Fage D; Scatton B
    Eur J Pharmacol; 1983 Sep; 93(1-2):55-62. PubMed ID: 6628547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M; Mataga N; Takashima M; Nishikawa T
    Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR; Emerich DF; el-Etri MM; Shipley MT; Zanol MD; Cahill DW; Norman AB
    Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin.
    Olgiati VR; Algeri S; Stramentinoli G
    Pharmacol Res Commun; 1987 Mar; 19(3):231-40. PubMed ID: 3602044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.